Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
NYSE:DGX
Holding DGX?
Track your performance easily
DGX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$123.04 - $165.32
Previous Close$162.44
Volume216.80K
Average Volume (3M)801.93K
Market Cap
$18.11B
Enterprise Value$24.45B
Total Cash (Recent Filing)$764.00M
Total Debt (Recent Filing)$6.97B
Price to Earnings (P/E)21.8
Beta0.28
Next Earnings
Jan 30, 2025EPS Estimate
$2.19Next Dividend Ex-Date
Jan 14, 2025Dividend Yield1.81%
Share Statistics
EPS (TTM)7.45
Shares Outstanding111,615,181
10 Day Avg. Volume1,013,202
30 Day Avg. Volume801,933
Standard Deviation0.09
R-Squared0.27
Alpha0.00196
Financial Highlights & Ratios
Price to Book (P/B)2.65
Price to Sales (P/S)1.89
Price to Cash Flow (P/CF)12.60
P/FCF Ratio15.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.56
Enterprise Value/Gross Profit8.01
Enterprise Value/Ebitda17.67
Forecast
1Y Price Target
$170.33Price Target Upside4.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Quest Diagnostics News
Bulls Say, Bears Say
Bulls Say
AcquisitionsM&A activity, including the acquisition of LifeLabs, is expected to serve as a tailwind to earnings over time as they benefit from Quest Diagnostics' scale and operations.
EarningsQuest Diagnostics has a clear line of sight into high-single digit EPS growth due to its strong base diagnostics business and stable labor environment.
Market TrendsStrength in the core testing business is driven by market share gains, expansion of medical guidance recommendations, and increased testing in additional therapeutic areas.
Bears Say
Cost PressuresAdjusted EBIT margins declined with pressures from ongoing wage inflation and mix from deals.
Operating PerformanceOperating margin was negatively impacted by weather disruptions and a global IT outage, resulting in missed operating income consensus estimates.
Risk/Reward ProfileThe current risk/reward profile of the stock is seen as balanced, with better fundamentals already reflected in valuation.
---
Ownership Overview
0.41% Insiders
27.88% Mutual Funds
15.74% Other Institutional Investors
28.87% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DGX FAQ
What was Quest Diagnostics’s price range in the past 12 months?
Quest Diagnostics lowest stock price was $123.04 and its highest was $165.32 in the past 12 months.
What is Quest Diagnostics’s market cap?
Currently, no data Available
When is Quest Diagnostics’s upcoming earnings report date?
Quest Diagnostics’s upcoming earnings report date is Jan 30, 2025 which is in 65 days.
How were Quest Diagnostics’s earnings last quarter?
Quest Diagnostics released its earnings results on Oct 22, 2024. The company reported $2.3 earnings per share for the quarter, beating the consensus estimate of $2.264 by $0.036.
Is Quest Diagnostics overvalued?
According to Wall Street analysts Quest Diagnostics’s price is currently Undervalued.
Does Quest Diagnostics pay dividends?
Quest Diagnostics pays a Quarterly dividend of $0.75 which represents an annual dividend yield of 1.81%. See more information on Quest Diagnostics dividends here
What is Quest Diagnostics’s EPS estimate?
Quest Diagnostics’s EPS estimate is $2.19.
How many shares outstanding does Quest Diagnostics have?
Quest Diagnostics has 111,615,180 shares outstanding.
What happened to Quest Diagnostics’s price movement after its last earnings report?
Quest Diagnostics reported an EPS of $2.3 in its last earnings report, beating expectations of $2.264. Following the earnings report the stock price went up 6.853%.
Which hedge fund is a major shareholder of Quest Diagnostics?
Among the largest hedge funds holding Quest Diagnostics’s share is Davis Selected Advisers. It holds Quest Diagnostics’s shares valued at 372M.
---
Quest Diagnostics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$170.33 (4.99% Upside)
$170.33 (4.99% Upside)
Blogger Sentiment
Bullish
DGX Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 523.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $5.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 4.3%
Last 30 Days ▲ 4.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.42%
12-Months-Change
Fundamentals
Return on Equity
12.66%
Trailing 12-Months
Asset Growth
19.38%
Trailing 12-Months
Company Description
Quest Diagnostics
Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
---
DGX Earnings Call
Q3 2024
0:00 / 0:00
---
DGX Revenue Breakdown
97.02% Diagnostic Information Services
2.98% All other operating segments
---
DGX Stock 12 Month Forecast
Average Price Target
$170.33
▲(4.99% Upside)
Technical Analysis
Best Analysts Covering DGX
1 Year
1 Year Success Rate
10/13 ratings generated profit
1 Year Average Return
+11.40%
reiterated a buy rating 2 days ago
Copying Eric Coldwell's trades and holding each position for 1 Year would result in 76.92% of your transactions generating a profit, with an average return of +11.40% per trade.
---